James S. Lewis

发表

Extended‐Spectrum β‐Lactamases: Epidemiology, Detection, and Treatment

D. Burgess, S. Nathisuwan, James S. Lewis, 2001 .

Detection systems for carbapenemase gene identification should include the SME serine carbapenemase.

Ryan M. Lee, K. Bush, J. Jorgensen, 2013, International journal of antimicrobial agents.

Oral and Parenteral Therapeutic Options for Outpatient Urinary Infections Caused by Enterobacteriaceae Producing CTX-M Extended-Spectrum β-Lactamases

B. Wickes, J. Jorgensen, James S. Lewis, 2009, Antimicrobial Agents and Chemotherapy.

Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city.

C. Murray, B. Wickes, J. Jorgensen, 2010, Diagnostic microbiology and infectious disease.

Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States.

S. Richter, D. Paterson, K. Shutt, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Current Options in Antifungal Pharmacotherapy

Melissa D. Johnson, T. Cooper, L. Ostrosky-Zeichner, 2008, Pharmacotherapy.

Trimethoprim-Sulfamethoxazole or Clindamycin for Community-Associated MRSA (CA-MRSA) Skin Infections

C. Frei, R. Talbert, C. Oramasionwu, 2010, The Journal of the American Board of Family Medicine.

Detection of SHV-Type Extended-Spectrum Beta-Lactamase in Enterobacter Isolates

B. Wickes, J. Jorgensen, James S. Lewis, 2009, Journal of Clinical Microbiology.

Comparison of posaconazole serum concentrations from haematological cancer patients on posaconazole tablet and oral suspension for treatment and prevention of invasive fungal infections

J. Bubalo, James S. Lewis, Aaron N Pham, 2016, Mycoses.

Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections

James S. Lewis, Michael W Ellis, 2005, Current opinion in infectious diseases.

Community-Associated Methicillin-Resistant Staphylococcus aureus: New Bug, Old Drugs

James S. Lewis, K. Echevarria, Kathryn Sabol, 2006, The Annals of pharmacotherapy.

Molecular Epidemiological Analysis of Escherichia coli Sequence Type ST131 (O25:H4) and blaCTX-M-15 among Extended-Spectrum-β-Lactamase-Producing E. coli from the United States, 2000 to 2009

J. Quinn, A. Robicsek, M. Kuskowski, 2012, Antimicrobial Agents and Chemotherapy.

CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales

A. Mathers, James S. Lewis, 2021, JAC-antimicrobial resistance.

The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing: Background, Organization, Functions, and Processes

M. Weinstein, James S. Lewis, 2020, Journal of Clinical Microbiology.

Efficacy and safety of cefepime.

James S. Lewis, K. Echevarria, Trent G. Towne, 2009, The Lancet. Infectious diseases.

Pharmacology of Systemic Antifungal Agents

D. Andes, James S. Lewis, E. Ashley, 2006 .

Outpatient antibiotic prescribing in the United States: 2000 to 2010

Grace C. Lee, C. Frei, K. Lawson, 2014, BMC Medicine.

Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection

T. Patterson, N. Wiederhold, James S. Lewis, 2008, Antimicrobial Agents and Chemotherapy.

Treatment of infections caused by resistant Staphylococcus aureus.

James S. Lewis, G. Anstead, Gabriel Quinones-Nazario, 2007, Methods in molecular biology.

The challenge of antibiotic selection in prosthetic joint infections due to Corynebacterium striatum: a case report

James S. Lewis, C. Varley, M. Sikka, 2022, BMC Infectious Diseases.

Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure

B. Wickes, J. Jorgensen, T. Patterson, 2013, Antimicrobial Agents and Chemotherapy.

Continuous versus Intermittent Infusion of Oxacillin for Treatment of Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus (cid:1)

D. Hughes, C. Frei, G. Crawford, 2009 .

The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety

N. Wiederhold, James S. Lewis, 2007, Expert opinion on pharmacotherapy.

First Report of the Emergence of CTX-M-Type Extended-Spectrum β-Lactamases (ESBLs) as the Predominant ESBL Isolated in a U.S. Health Care System

B. Wickes, J. Jorgensen, J. Patterson, 2008, Antimicrobial Agents and Chemotherapy.

A Reference Laboratory Experience of Clinically Achievable Voriconazole, Posaconazole, and Itraconazole Concentrations within the Bloodstream and Cerebral Spinal Fluid

T. Patterson, A. Fothergill, D. Sutton, 2013, Antimicrobial Agents and Chemotherapy.

Development of Daptomycin Susceptibility Breakpoints for Enterococcus faecium and Revision of the Breakpoints for other Enterococcal species by the Clinical and Laboratory Standards Institute.

M. Weinstein, R. Humphries, J. Jorgensen, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of Cefazolin versus Oxacillin for Treatment of Complicated Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus

D. Hughes, Jason E. Bowling, James S. Lewis, 2014, Antimicrobial Agents and Chemotherapy.

Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy.

James S. Lewis, Miguel Gonzalez-Velez, J. Cadena, 2012, The Journal of antimicrobial chemotherapy.

Retrospective cohort study of hospitalized adults treated with vancomycin or clindamycin for methicillin-resistant Staphylococcus aureus skin infections.

C. Frei, R. Talbert, K. Lawson, 2010, Clinical therapeutics.

Pharmacology and clinical use of voriconazole

James S. Lewis, G. Thompson, 2010, Expert opinion on drug metabolism & toxicology.

Outpatient Parenteral Antimicrobial Therapy

Jason E. Bowling, James S. Lewis, Aaron Owens, 2013 .

Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients

James S. Lewis, M. Hakki, 2018, Infection.

Emergence of Daptomycin Resistance in Enterococcus faecium during Daptomycin Therapy

J. Jorgensen, J. Patterson, James S. Lewis, 2005, Antimicrobial Agents and Chemotherapy.

Breakthrough Bacteremia and Septic Shock Due to Streptococcus anginosus Resistant to Daptomycin in a Patient Receiving Daptomycin Therapy

J. Jorgensen, James S. Lewis, K. Echevarria, 2011, Antimicrobial Agents and Chemotherapy.

Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir.

T. Patterson, James S. Lewis, G. Thompson, 2010, Medical mycology.

Micafungin Concentrations from Brain Tissue and Pancreatic Pseudocyst Fluid

M. Rinaldi, G. Pennick, James S. Lewis, 2010, Antimicrobial Agents and Chemotherapy.

Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience

M. Rinaldi, T. Patterson, G. Pennick, 2009, Antimicrobial Agents and Chemotherapy.

Approaches to serious methicillin-resistant Staphylococcus aureus infections with decreased susceptibility to vancomycin: clinical significance and options for management

James S. Lewis, Michael W Ellis, 2007, Current opinion in infectious diseases.

Failure of Cefepime Therapy in Treatment of Klebsiella pneumoniae Bacteremia

Wonkeun Song, J. Jorgensen, E. S. Moland, 2005, Journal of Clinical Microbiology.

New Perspectives on Antimicrobial Agents: Isavuconazole

N. Wiederhold, James S. Lewis, M. Hakki, 2022, Antimicrobial agents and chemotherapy.

Cefepime for Gram-negative bacteremia in long-term hemodialysis: a single-center experience.

D. Hughes, K. Perez, James S. Lewis, 2012, American Journal of Kidney Diseases.

Fungicidal versus Fungistatic: what's in a word?

J. Graybill, James S. Lewis, 2008, Expert opinion on pharmacotherapy.

Cost Advantage of Voriconazole over Amphotericin B Deoxycholate for Primary Treatment of Invasive Aspergillosis

T. Lubowski, H. Boucher, T. Patterson, 2005, Pharmacotherapy.

Isavuconazole prophylaxis in patients with hematologic malignancies and hematopoietic-cell transplant recipients.

B. Noble, D. Perlin, L. Strasfeld, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Refractory coccidioidomycosis treated with posaconazole.

J. Graybill, James S. Lewis, G. Anstead, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis.

T. Patterson, James S. Lewis, D. Nix, 2019, Medical mycology.

Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations

J. Bubalo, James S. Lewis, Tina M Gu, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients

Amber H Diaz, J. Bubalo, James S. Lewis, 2022, Antimicrobial agents and chemotherapy.

KPC-2-Producing Enterobacter cloacae and Pseudomonas putida Coinfection in a Liver Transplant Recipient

J. Jorgensen, J. Bennett, James S. Lewis, 2008, Antimicrobial Agents and Chemotherapy.

Comparison of cefazolin versus oxacillin for the treatment of complicated bacteremia

D. Hughes, James S. Lewis, K. Echevarria, 2014 .

Clinical Outcomes of Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections

C. A. Holmes, G. Forrest, B. Noble, 2018, Antimicrobial Agents and Chemotherapy.

Clinical Outcomes of the Oral Suspension vs Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections

C. A. Holmes, G. Forrest, B. Noble, 2017, Open Forum Infectious Diseases.

Rezafungin: a novel antifungal for the treatment of invasive candidiasis.

James S. Lewis, G. Thompson, Young Yoon Ham, 2021, Future microbiology.

Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) position statements on polymyxin B and colistin clinical breakpoints.

M. Weinstein, R. Humphries, J. Turnidge, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Detection of Favorable Oral Cephalosporin-Clavulanate Interactions by In Vitro Disk Approximation Susceptibility Testing of Extended-Spectrum-Beta-Lactamase-Producing Members of the Enterobacteriaceae

J. Jorgensen, James S. Lewis, L. Fulcher, 2011, Journal of Clinical Microbiology.

Monotherapy or Combination Therapy? The Pseudomonas aeruginosa Conundrum

James S. Lewis, K. Echevarria, Kay Green, 2011, Pharmacotherapy.

The Need for Antiviral Drugs for Pandemic Coronaviruses From a Global Health Perspective

James S. Lewis, Sara J Gore, J. S. Doggett, 2020, Frontiers in Medicine.

Effects of therapeutic drug monitoring criteria in a computerized prescriber-order-entry system on the appropriateness of vancomycin level orders.

C. Frei, James S. Lewis, Kay Green, 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Clinical and Microbiologic Analysis of a Hospital's Extended‐Spectrum β‐Lactamase‐Producing Isolates Over a 2‐Year Period

J. Jorgensen, D. Burgess, J. Patterson, 2003, Pharmacotherapy.

Evaluation of Opportunities for Oral Antibiotic Therapy in Bone and Joint Infections

James S. Lewis, M. Sikka, Jina T. Makadia, 2022, The Annals of pharmacotherapy.

Continuous versus Intermittent Infusion of Oxacillin for Treatment of Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus

D. Hughes, C. Frei, G. Crawford, 2009, Antimicrobial Agents and Chemotherapy.

Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?

J. Jorgensen, James S. Lewis, James S Lewis, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acute renal allograft thrombosis in ‘seronegative’ antiphospholipid syndrome

S. Akilesh, H. Liapis, James S. Lewis, 2008, NDT plus.

Failure of Clindamycin To Eradicate Infection with Beta-Hemolytic Streptococci Inducibly Resistant to Clindamycin in an Animal Model and in Human Infections

W. Craig, D. Andes, J. Jorgensen, 2013, Antimicrobial Agents and Chemotherapy.

Clinical and Microbiologic Characteristics of Cephalosporin-Resistant Escherichia coli at Three Centers in the United States

K. Shutt, J. Jorgensen, Y. Doi, 2012, Antimicrobial Agents and Chemotherapy.

First Report of the Emergence of CTX-M-Type Extended-Spectrum β-Lactamases (ESBLs) as the Predominant ESBL Isolated in a U.S. Health Care System

B. Wickes, J. Jorgensen, J. Patterson, 2007, Antimicrobial Agents and Chemotherapy.

Escherichia coli in Three Centers in the United States

J. Jorgensen, Y. Doi, James S. Lewis, 2012 .

Dalbavancin use in an academic medical center and associated cost-savings.

James S. Lewis, M. Sikka, C. Bowen, 2019, International journal of antimicrobial agents.

Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review

J. Bennett, James S. Lewis, Michael W Ellis, 2008, Therapeutics and clinical risk management.

Daptomycin-induced acute eosinophilic pneumonia: Analysis of the current data and illustrative case reports

T. Patterson, James S. Lewis, A. Cardile, 2013, Scandinavian journal of infectious diseases.

Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process

S. Cosgrove, David R Ha, P. Tamma, 2021, Open forum infectious diseases.

Impact of a Clostridioides difficile testing computerized clinical decision support on an adult stem cell transplant and hematologic malignancies unit.

W. Messer, L. Strasfeld, James S. Lewis, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Unintended consequences of a reflex urine culture order set on appropriate antibiotic use

Miriam R. Elman, J. Townes, James S. Lewis, 2020, Infection control and hospital epidemiology.

Antimicrobial Selection and Length of Hospital Stay in Patients with Community-Acquired Pneumonia

William Krebs, T. Lubowski, K. P. Ravikrishnan, 2002 .

Severe myopathy and possible hepatotoxicity related to daptomycin.

James S. Lewis, K. Echevarria, J. Cadena, 2005, The Journal of antimicrobial chemotherapy.

Rapid detection of blaOXA in carbapenem-susceptible Acinetobacter radioresistens bacteremia leading to unnecessary antimicrobial administration.

C. Pfeiffer, James S. Lewis, Adam C. Brady, 2016, Diagnostic microbiology and infectious disease.

Safety and efficacy of direct two-step penicillin challenges with an inpatient pharmacist-driven allergy evaluation.

James S. Lewis, S. Joshi, Diana Yu, 2021, Allergy and asthma proceedings.

Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.

R. Humphries, P. Hemarajata, R. Mettus, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Echinocandin activity against Aspergillus spp. and the importance of pharmacodynamics.

James S. Lewis, 2009, Medical mycology.

Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management

J. Baddley, M. Hoenigl, T. Patterson, 2023, Clinical microbiology reviews.

Posaconazole Tablet Formulation at 400 Milligrams Daily Achieves Desired Minimum Serum Concentrations in Adult Patients with a Hematologic Malignancy or Stem Cell Transplant

J. Bubalo, James S. Lewis, Aaron N. Pham, 2016, Antimicrobial Agents and Chemotherapy.

Therapeutic drug monitoring of antifungal agents

James S. Lewis, 2009 .

Performance standards for antimicrobial susceptibility testing

Clinical, B. Zimmer, M. Weinstein, 2019 .

Case Commentary: Successful Use of Cefepime/Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing Pseudomonas aeruginosa Infection in an Adult Patient with Acute T-Cell Leukemia

James S. Lewis, M. Hakki, Stephanie L Egge, 2023, Antimicrobial agents and chemotherapy.

Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia.

D. Burgess, J. Lewis, James S. Lewis, 2000, Clinical therapeutics.